Triamcinolone Hexacetonide Injection Shortage
Last Updated: July 25, 2025
Status: Current
Products Affected - Description
-
- Hexatrione injection, Medexus Pharma, 20 mg/mL, 2 mL ampule, 1 count, NDC 59137-0570-01
Reason for the Shortage
-
- Sandoz discontinued Aristospan in September 2020.
Available Products
-
- There are no presentations available
Estimated Resupply Dates
-
- Medexus in conjunction with FDA has had initiated a temporary importation of Triamcinolone Hexacetonide (Hexatrione 2%) injectable suspension 20 mg/mL 2 mL ampules (NDC 59137-0570-01), to the U.S. market to address drug shortage. Currently this product is unavailable to order. Once it is available again, please contact ANDA at1-855-336-3322, Option # 9. There is a side by side comparison between Aristospan and Hexatrione available at https://www.fda.gov/media/154709/download.
Implications for Patient Care
-
- Triamcinolone hexacetonide injection is commonly used as an intraarticular injection for inflammatory joint diseases.[1]
Alternative Agents & Management
-
- Refer to Table 1 for alternative corticosteroids available as depot injections. Alternative agents may also experience supply shortages.
- Clinical guidelines from American Academy of Orthopaedic Surgeons (AAOS), American College of Rheumatology (ACR), European League Against Rheumatism (EULAR), and do not endorse one intraarticular corticosteroid over another for short-term pain relief in inflammatory joint diseases.[2-5]
Table 1. Recommended dosing of Corticosteroids Available as Depot Formulations[1 6 7] Agent Large Joint Intraarticular Dosing Medium Joint Intraarticular Dosing Small Joint Intraarticular Dosing Triamcinolone acetonide 20 - 40 mg 20 - 30 mg 8 - 10 mg Triamcinolone acetonide extended-release 32 mg 32 mg Not suitable Triamcinolone hexacetonide 10 - 20 mg 10 - 20 mg 2 - 6 mg Methylprednisolone acetate 20 - 80 mg 10 - 20 mg 4 - 10 mg Betamethasone sodium phosphate/acetate 6 - 12 mg 3 - 6 mg 1.5 - 3 mg
References
-
- Triamcinolone. UpToDate Lexidrug, Lexi-Drugs Online. Waltham, MA, 2023.
- Benzon HT, Provenzano DA, Nagpal A, et al. Use and safety of corticosteroid injections in joints and musculoskeletal soft tissue: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, the American Society of Interventional Pain Physicians, and the International Pain and Spine Intervention Society. Regional anesthesia and pain medicine 2025 doi: 10.1136/rapm-2024-105656[published Online First: Epub Date]|.
- Brophy RH, Fillingham YA. AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition. The Journal of the American Academy of Orthopaedic Surgeons 2022;30(9):e721-e29 doi: 10.5435/jaaos-d-21-01233[published Online First: Epub Date]|.
- Navani A, Manchikanti L, Albers SL, et al. Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain physician 2019;22(1s):S1-s74
- Uson J, Rodriguez-GarcÂa SC, Castellanos-Moreira R, et al. EULAR recommendations for intra-articular therapies. Annals of the rheumatic diseases 2021;80(10):1299-305 doi: 10.1136/annrheumdis-2021-220266[published Online First: Epub Date]|.
- Betamethasone. UpToDate Lexidrug, Lexi-Drugs Online. Waltham, MA, 2023.
- Methylprednisolone. UpToDate Lexidrug, Lexi-Drugs Online. Waltham, MA, 2023.
Updated
Updated July 25, 2025 by Rachael Freeman, PharmD, BCPS. Created June 22, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.